Stockreport

Sagimet Biosciences Highlights Denifanstat MASH Data, Combo Plans at Oppenheimer Healthcare Conf. [Yahoo! Finance]

Sagimet Biosciences Inc. - Series A  (SGMT) 
PDF significance—showing fibrosis improvement without worsening MASH and MASH resolution without worsening fibrosis—while digital pathology supported results and patients on [Read more]